Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Med Venture Partners Named to Inc. 5000


MVP Health Logo

Inc. magazine today revealed that Med Venture Partners LLC is No. 2,367 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“Magical things happen when a team gives selflessly to the companies vision.” Donald Smith-CEO

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth of over 500 percent, and a median rate of 165 percent. The Inc. 5000’s aggregate revenue was $209 billion in 2019, accounting for over 1 million jobs over the past three years.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are also being featured in the September issue of Inc., available on newsstands August 12.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

The annual Inc. 5000 event honoring the companies on the list will be held virtually from October 23 to 27, 2020. As always, speakers will include some of the greatest innovators and business leaders of our generation.

CONTACT: Ryan Smith, 443.899.4775, Smith@mvp-rx.com,

More about Inc. and the Inc. 5000

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

For more information on the Inc. 5000 Conference, visit http://conference.inc.com/.

Share article on social media or email:

Compliancy Group makes the 2020 Inc. 5000 Fastest Growing Private Companies in America


Inc. 5000

Inc. 5000

“We believe TRUST to be the key issue in compliance. In these challenging times we greatly appreciate the industry recognition and endorsement we receive. Thank you to our clients, partners, and employees for they are why we have won this national recognition by Inc.”

Compliancy Group has joined an elite few as one of 2020 Inc. 5000 Fastest Growing Private Companies in America. Earlier this year, Compliancy Group was also listed as one of Inc. 2020 Best Places to Work.

In these unprecedented times, stability, certainty, and reliability can mean all the difference to your success. Compliancy Group is the only compliance firm to be listed on both Inc. 2020 Best Places to Work and 2020 Inc. 5000 list of the fastest-growing private companies in America.

Compliancy Group is No. 1770 on the annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth, with Compliancy Group’s growth rate at 241.76%.

“We believe TRUST to be the key issue in compliance. In these challenging times we greatly appreciate the industry recognition and endorsement we receive. Thank you to our clients, partners, and employees for they are why we have won this national recognition by Inc. This award will continue to give our clients and partners comfort that they have chosen the best compliance solution in the market,” Marc Haskelson, President and CEO Compliancy Group.

Compliancy Group strives to keep our employees focused and happy, not only to provide the best place to work, but to be the best place to work with! Inclusion on the Inc. 5000 list demonstrates Compliancy Group’s commitment to growing to serve the needs of the compliance market.

Compliancy Group client Susan Butts of Cox HealthPlans states, “This vendor is one of my favorite vendors. They drive you to compliance. Every person I have worked with in this company is knowledgeable, upbeat, and always understands their clients. Definite recommendation from me!”

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are also being featured in the September issue of Inc., available on newsstands August 12.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

About Compliancy Group:

HIPAA should be simple. That’s why Compliancy Group is the only HIPAA software with expert Compliance CoachesTM holding your hand to simplify compliance. Built by auditors, Compliancy Group gives you confidence in your compliance plan to reduce risk, increase patient loyalty, and profitability of your organization.

Why Compliancy Group?

HIPAA Audit Support, no client has ever failed an audit!

Total Solution

HIPAA Seal of Compliance

Dedicated Compliance Coaches

Visit compliancy-group.com or call 855.854.4722 to learn how simple compliance can be.

Compliancy Group Resources:

Free HIPAA Compliance Checklist

About HIPAA

HIPAA Checklist

HIPAA Training

More about Inc. and the Inc. 5000

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

For more information on the Inc. 5000 Conference, visit https://conference.inc.com/.

Share article on social media or email:

AANP selects Korn/Ferry International to lead recruitment for new Chief Executive Officer


“With our dedicated professional staff and a strong strategic plan, we look forward to the continued growth of the organization and of the nurse practitioner (NP) role.”

The American Association of Nurse Practitioners® (AANP) has selected Korn Ferry International, a leading global recruitment and talent management firm, to work with a committee appointed from within AANP to select the next Chief Executive Officer (CEO) for the organization. The search is underway and should be completed by the year-end. More information is available here.

Tom Giella, Chairman, Healthcare Services, and Lorraine Lavet, Sector Leader, National Association Practice, are leading the search from Korn Ferry. Interested candidates should apply directly to Kelly Ashmore, Associate, Healthcare Services (Kelly.ashmore@kornferry.com or 312-526-0561).

AANP announced earlier this year that CEO David Hebert, JD, will retire in December 2020 after eight years at the helm of the largest national membership organization for nurse practitioners (NPs) of all specialties. “AANP is most appreciative of the leadership that David Hebert has provided to our organization,” said AANP President Sophia L. Thomas, DNP, APRN, FNP-BC, PPCNP-BC, FNAP, FAANP. “With our dedicated professional staff and a strong strategic plan, we look forward to continued growth of the organization and of the nurse practitioner (NP) role.”

The American Association of Nurse Practitioners® (AANP) is the largest professional membership organization for nurse practitioners (NPs) of all specialties. It represents the interests of the more than 290,000 licensed NPs in the U.S. AANP provides legislative leadership at the local, state, and national levels, advancing health policy; promoting excellence in practice, education and research; and establishing standards that best serve NP patients and other health care consumers. As The Voice of the Nurse Practitioner®, AANP represents the interests of NPs as providers of high-quality, cost-effective, comprehensive, patient-centered health care. To locate a nurse practitioner in your community, go to npfinder.com. For more information about NPs, visit aanp.org.

Share article on social media or email:

Boulder Biotech Company Doubles Sterilization Capacity for Medical Device Products


Boulder iQ is an expert contract consulting firm offering design engineering, development, and turnkey manufacturing for consumer, high-technology and medical products, and regulatory, clinical and quality compliance services for medical device and in vitro diagnostic companies.

Boulder iQ offers design engineering, development and manufacturing for consumer, high-tech and medical products, and regulatory, clinical and quality compliance for med device and IVD companies.

Doubling capacity is part of Boulder iQ’s effort to help medical device companies get products to market quickly and efficiently, with a commitment to maintaining a four-day turnaround for most sterilization services.

Boulder iQ, a contract consulting firm for high-technology and medical products, is doubling its capacity for ethylene oxide (EO) sterilization of medical devices in a commitment to maintain a four-day turnaround for most sterilization services.

The company’s Boulder Sterilization division uses ethylene oxide, a safe, effective low-temperature method, to sterilize medical device equipment and accessories from biological contaminants, including those from COVID-19. In addition, Boulder Sterilization uses an abator (catalytic converter) system to mitigate outgassing that is inherent in the EO process. While not required in Colorado, the company has opted to incorporate the abator to underscore its commitment to green operations.

“Perhaps now more than ever, medical device companies need to get products to market quickly and efficiently,” says Jim Kasic, Boulder iQ’s president and CEO. He cites the fact that with the increased capacity, Boulder Sterilization can accommodate more projects to better serve its clients. “For entrepreneurs, start-ups and established companies that require sterilization of products, the service that Boulder Sterilization offers is quick, efficient, flexible and reliable.”

Offering sterilization, regulatory assistance during COVID crisis

Boulder Sterilization process works for healthcare and personal protection equipment (PPE), including N-95 respirators, surgical gowns, and nasal swabs, as well as medical devices and accessories used in COVID-19 testing, treatment, and care. In these times of PPE shortages, respirators, gowns, and swabs need regular cleaning and decontamination for reuse, explains Kasic.

Boulder Sterilization also offers sterile packaging for medical devices sealed in Tyvek pouches, common packaging for medical devices.

Through its regulatory consulting service, Boulder iQ is assisting companies in preparing Emergency Use Authorizations for medical devices and in vitro diagnostics. During a public health emergency, the FDA can use its Emergency Use Authorization authority to allow the use of uncleared or unapproved medical products – or allow for uncleared or unapproved uses of cleared or approved medical products – to diagnose, treat, or prevent serious diseases, such as COVID-19, when certain criteria are met.

Boulder iQ (http://www.boulderiq.com)

Boulder iQ is an expert contract consulting firm offering design engineering, development, and turnkey manufacturing for consumer, high-technology and medical products, and regulatory, clinical and quality compliance services for medical device and in vitro diagnostic companies. Based in Boulder, Colorado, the company is ISO 13485:2016 certified through Boulder BioMed.

The company’s Boulder Sterilization division provides ethylene oxide sterilization services. Boulder iQ’s Boulder Medical Device Accelerator provides equity investment in start-up companies seeking product development services, expert mentoring and infrastructure support.

Share article on social media or email:

AltMed Florida’s 24th MÜV™ Medical Cannabis Dispensary Brings Economic Growth to West Palm Beach


News Image

Our dispensaries are a cut above the rest. They set the standard for quality products, service and overall patient experience. We’re excited to offer our premium MÜV medical cannabis brand to West Palm Beach area patients

AltMed Florida, one of the biggest privately-owned cannabis companies in America, continues its expansion with a three-day opening, starting Monday Aug.17, 2020 at 10am for its newest MÜV™ Medical Cannabis Dispensary at 313 Datura St. Ste. 101, West Palm Beach.

Located in the downtown hub of West Palm Beach, this new MÜV dispensary is within walking distance of the city’s beautiful waterfront and the Meyer Amphitheater. It is surrounded by shops, residences and restaurants making it easily accessible by foot or by car.

The dispensary is bringing new life to Halsey Place, a building that was built in 1924 and has served as a stationary store, an office supply store, a hotel and a carriage house. This is MÜV’s second dispensary in Palm Beach county. The first is 13 miles west in Wellington.

“We’ve enjoyed phenomenal success at our Wellington dispensary since opening in February 2019,” said Todd Beckwith, AltMed Director of Corporate Affairs. “Many customers who were visiting us in Wellington kept asking when we would open a dispensary in West Palm Beach. We’re excited to be able to say, the time is now.”

The West Palm Beach MÜV Dispensary will serve patients on the busy Intersate-95 corridor from Palm Beach, Lake Worth, Boynton Beach, Jupiter and beyond.

“Our dispensaries are a cut above the rest,” said John Tipton, AltMed Florida CEO. “They set the standard for quality products, service and overall patient experience. We’re excited to offer our premium MÜV medical cannabis brand to West Palm Beach area patients.”

During the opening, staggered over three-days (Aug.17-Aug.19) for crowd mitigation, all licensed Florida medical cannabis patients will receive a one-time use only, one per patient, 25 percent off their entire first purchase. Patients are also encouraged to order at muvfl.com for express pickup or delivery to help reduce heavy traffic.

Deemed an essential service during the pandemic, AltMed Florida has been able to expand its workforce to over 500 employees with additional teams coming onboard at each of its 13 new dispensaries this year. With higher demand for products from 24 total dispensaries, AltMed has also generated additional construction employment and staffing with the expansion of its 220,000-square-foot cultivation facility in Apollo Beach.

The newest state-of-the-art MÜV dispensary will offer an extensive selection of award-winning products including flower, pre-rolls, a wide range of vaporizer pens, metered dose inhalers, topicals, oral sprays, patent-pending encapsulation formulations in its Tinctures, 72-Hour Transdermal patches and transdermal gels. MÜV is also has one of the widest selections of concentrates for patients’ needing macro-dosing options.

Like AltMed Florida’s 23 other locations (Apollo Beach, Bradenton, Bonita Springs, Clearwater, Deerfield Beach, Fort Myers, Gainesville, Jacksonville/San Marco, Jacksonville Beach, Lady Lake, Lakeland, Longwood/Orlando, Lutz, North Port, downtown Orlando, Ormond Beach, Pensacola, Sebastian, Sarasota, St. Petersburg, Tallahassee, Tampa, Wellington) the new West Palm Beach MÜV Dispensary stands out because it’s designed as a premium experience – think Apple Store, with a modern open-concept design and expert staff with extensive training.

The MÜV brand already has a wide following in other legal medical cannabis markets, including Arizona, where it has won five Best of Arizona medical cannabis awards. MÜV products are sold exclusively in Florida at MÜV dispensaries because, unlike other states, Florida does not allow wholesale of product between license holders – only products that license holders make themselves can be sold in their dispensaries.

For more information about the new ADA-compliant MÜV Medical Cannabis Dispensary in West Palm Beach, including hours and available MÜV products, visit muvfl.com.

AltMed Florida is on pace to open 40 MÜV Medical Cannabis Dispensaries across the state, all supplied by its 220,000-square-foot, state-of-the-art cultivation facility. Visit this link for images of AltMed Florida’s cultivation operations and watch this brief video to see what makes AltMed Florida and its MÜV™ Medical Cannabis Dispensaries stand out.

About Plants of Ruskin, LLC – d.b.a. AltMed Florida, LLC – With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.

About AltMed Enterprises – Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated medical cannabis company that brings compassion, community engagement and pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.

About MÜV™ – The MÜV brand of cannabis infused products was launched in Arizona in 2016 and quickly gained international attention and recognition. In its first six months alone, MÜV received four best of Arizona medical cannabis awards, including two first prizes for its proprietary Ethanol extractions that are the basis of all MÜV products.

Forward-Looking Statements -

To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.

RXNT Repeats on Inc. Magazine’s List of Top 5000 Fastest Growing Private Companies


Inc. 5000 image

RXNT recognized by Inc. Magazine again in 2020

On behalf of the entire RXNT team, I am so honored to accept this award for the second consecutive year.

RXNT Inc. is thrilled to announce that we have been honored for the second year in a row by Inc. magazine as one of America’s 5000 Fastest-Growing Private Companies. RXNT earned this achievement with a three-year revenue growth of 91% during a stretch when the economy grew by 15%. Other technology companies which have appeared on past lists include industry leaders, such as Microsoft, Oracle, LinkedIn, Yelp, and Zillow.

“On behalf of the entire RXNT team, I am so honored to accept this award for the second consecutive year. RXNT continues to offer innovative solutions that help healthcare professionals and medical billing firms achieve their clinical and business goals. We share this award with our clients who trust us to be their technology partner in providing the highest quality care to their patients. Since 1999, we’ve grown from a single product company to one offering a fully-integrated suite of solutions. I feel like we’re just hitting our stride and I’m excited for our future,” said Randy Boldyga, CEO, President, and Founder of RXNT.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

The annual Inc. 5000 event honoring the companies on the list will be held during a virtual conference October 19-23, 2020. As always, speakers include some of the greatest innovators and business leaders of our generation.

More about Inc. and the Inc. 5000

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

About RXNT

Since 1999, RXNT has provided award-winning and certified eRx, EHR, and Practice Management and Billing solutions to physician practices, healthcare providers and medical billing companies. The company’s cost-effective, fully-integrated and cloud-based systems are designed to provide robust functionality while being easy to implement and use. For additional information, please visit http://www.rxnt.com.

For more information, please contact:

Tom Collinson

Executive Vice President, Business Development

410-777-8842

tcollinson@RXNT.com

Share article on social media or email:

Phase 2/3 trial suggests that AMZELL’s new topical treatment (AMZ001) for the treatment of knee osteoarthritis symptoms is effective


Reference: Bihlet A.R, Byrjalsen I, Nielsen H.B, Andersen J.R, Derne C, Delpy L, Carrara D,  A placebo-controlled, double-blind, randomized, trial of AMZ001 - a novel diclofenac sodium 3.06% gel - for the treatment of knee osteoarthritis symptoms.

Fig.1 Statistical analysis of treatment differences (95% CI) between placebo vs AMZ001 BID, AMZ001 QD, & Voltaren® 1% for the a) planned & b) post-hoc analysis of primary & key secondary endpoints

Dr Lee S Simon, Rheumatologist: “It is clear that topical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) can be important therapies for patients with osteoarthritis of the knee. Guidelines recommend these therapies as first line in patients who do not respond to weight loss & exercise alone.”

This phase 2/3 multi-center, randomized, double-blind trial investigated the effect of a new 3.06% diclofenac sodium gel formulation (AMZ001) for the relief of knee OA pain, in 444 patients exposed to either AMZ001 once daily (QD), AMZ001 twice daily (BID) or placebo. The trial also included an exploratory comparator treatment arm, Voltaren® Gel 1 % four times daily (QID).

For the primary analysis of change from baseline to week 4 in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain sub-score, AMZ001 QD showed a nominally significant improvement in reducing the pain compared to placebo (p<0.05). The results suggest that differences for BID were borderline significant (p<0.10).

The post-hoc analysis, including patients meeting WOMAC pain inclusion criterion at screening and baseline (89% of enrolled subjects), demonstrated nominally statistically significant reductions in WOMAC pain sub-scores compared to placebo for AMZ001 BID (p=0.029) and AMZ001 QD (p=0.019); differentiation to placebo was also strengthened for efficacy endpoints, as shown in Figure 1b.

While the study design and differences in samples sizes prevent formal comparisons between the AMZ001 treatment arms and the active comparator arm, there were no statistically significant differences between Voltaren® gel 1% QID compared with placebo or any AMZ001 regimens for all endpoints.

The safety and tolerability of AMZ001 was favorable with a low frequency of adverse events leading to discontinuation (2.5% to 6.6%) comparable to Voltaren® Gel 1% (6.2%). No serious adverse events were reported during the trial.

Dr. Lee S. Simon, Rheumatologist commented: “It is clear that topical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) can be important therapies for patients with osteoarthritis of the knee. Guidelines recommend these therapies as first line in patients who do not respond to weight loss and exercise alone.

The results of this study are very encouraging for the hundreds of millions of patients with knee OA which represent 80% of the total burden of OA. Reducing the number of applications per day could help with adherence and thus help to reduce the chronic pain that could be caused by this disease.”

The study also found regarding secondary endpoints that the patients treated with AMZ001 experienced consistent improvements in quality of life (EQ-5D VAS questionnaire), in patient global assessment (PGA) and in productivity and activity (Work Productivity and Activity Index – WPAI) as shown in Figure 1a. These results are encouraging, considering that arthritis/rheumatism is the third leading cause of work disability in the Unites States after back/neck problems and depression/anxiety.[Ref1] Systemic exposure data indicated that AMZ001 delivers the active agent to the targeted tissue reducing the exposure to other body systems. This local action could be an asset in an elderly patient population who is usually on several drugs for ageing-associated diseases.

Dario N. Carrara PhD, Chief Scientific Officer commented: “This is the first study that investigated the efficacy of topical diclofenac on a once daily regimen in patients suffering from osteoarthritis of the knee. Our product takes advantage of the company’s proprietary topical transdermal technology to decrease the need for treatment to once a day in comparison to Voltaren® 1% four times daily gel.”

Fig. 1. Shows a statistical analysis of treatment differences (95% CI) between placebo vs AMZ001 BID, AMZ001 QD, and Voltaren® 1% for the a) planned and b) post-hoc analysis of primary and key secondary endpoints (mITT set)[Ref2]

1 Positive value indicate improvement.

2 WPAI scores presented for overall work impairment sub-score, normalized 0–100.

Note: WOMAC, EQ-5D VAS, PGA and ICOAP scores are normalized 0–100.

BID: twice daily; CI: confidence interval; EQ-5D: EuroQol-5 Domain Questionnaire; ICOAP: intermittent and constant OA pain; mITT: modified intention-to-treat; OA: osteoarthritis; PGA: Patient Global Assessment;

QD: once daily; VAS: visual analog scale; WOMAC: Western Ontario and McMasters Universities Osteoarthritis Index; WPAI: Work Productivity and Activity Impairment questionnaire.

Note: Treatment differences vs placebo (95% CI) are presented for all endpoints; scores were normalized 0–100.

About Amzell

Amzell B.V is a specialist, virtual development pharmaceutical company which takes candidate or repurposed drugs and devices either through to proof of concept, or through to registration for sale to commercial healthcare companies.

Amzell B.V has particular interest in developing well-characterized active substances utilizing innovative platform drug delivery technologies, with the aim to provide more effective drug delivery, increased efficacy, and improved safety and compliance.

AMZ001 – topical diclofenac gel for the treatment of pain related to knee osteoarthritis

AMZ001 is a non-invasive topical gel formulation containing 3.06% diclofenac sodium which is a nonsteroidal anti-inflammatory drug (NSAID). Each dose of AMZ001 is accurately administered by an airless metered dose pump.

Its higher drug strength (3.06%) combined with an efficient topical delivery system allows AMZ001 to improve localized pain with a single daily application (QD), with a lower total dose compared to other topical NSAIDs treatments.

[Ref1] Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Curr Opin Rheumatol 2018;30:160–7

[Ref2] Bihlet A.R, Byrjalsen I, Nielsen H.B, Andersen J.R, Derne C, Delpy L, Carrara D, A placebo-controlled, double-blind, randomized, trial of AMZ001 – a novel diclofenac sodium 3.06% gel – for the treatment of knee osteoarthritis symptoms. Abstract 725. Osteoarthritis and Cartilage, volume 28,supplement 1, S484, 01 April 2020.

Share article on social media or email:

Comprehensive Dental Implant Treatment Now Available from Periodontist and Prosthodontist Team in Eden Prairie, MN


Dr. Andres Sanchez Periodontist in Eden Prairie, MN

Periodontist, Dr. Andres Sanchez Offers Dental Implants in Eden Prairie, MN

Experienced periodontist Dr. Andres R. Sanchez and prosthodontist Dr. Eleni Voltidi of PerioWest now provide more personalized and comprehensive treatment for patients with missing teeth. The team completes all surgical and restorative phases of dental implant treatment in a single location at their Eden Prairie, MN practice, providing patients with greater levels of convenience and safety during the COVID-19 pandemic.

PerioWest specializes in comprehensive dental implant treatment for patients with any number of missing teeth. Recently welcoming esteemed prosthodontist Dr. Voltidi to the team of implant specialists allows the practice to provide custom restorations in-house, in addition to tooth extractions, gum disease therapy, bone grafting, and implant surgery, all from the same practice location. Patients can enjoy even greater quality and efficiency of dental implant care from a single team of dedicated specialists who collaborate to create personalized and comprehensive treatments. With both periodontal and prosthodontic expertise, the team consistently exceeds patient expectations with innovative dental implant treatment, including same-day dental implants, for one, several, or all missing teeth.

Dental implants make it possible for patients to restore dental function for healthy eating, a complete smile for proper aesthetics, and confidence in strong, stable teeth. With the restored ability to bite and chew a variety of foods, patients can improve their oral and overall health during the COVID-19 pandemic with a nutritional diet. Proper physical health and a healthy immune system are critical in the body’s fight against dangerous infections and viruses. Dental implants can also restore a patient’s sense of confidence and self-esteem, helping them return to an active and social life, and an overall better quality of life.

The PerioWest team is excited to be able to offer even more comprehensive treatment at their practice so they can provide this life-changing solution efficiently and predictably. They also encourage patients to seek their treatments, which are all completed in a single location, to minimize multiple in-person appointments and help limit the spread of COVID-19. In addition to providing safe and calming treatment experiences, the PerioWest team takes advanced sanitization measures based on the most up-to-date Centers for Disease Control and Prevention (CDC) guidelines.

Patients with missing teeth interested in receiving comprehensive dental implant treatment from one specialized team in Eden Prairie, MN can contact PerioWest by calling 952-567-7457 or visiting http://www.periowestmn.com.

About the Practice

PerioWest is a periodontal practice offering personalized dental care for patients in Eden Prairie, MN and the Twin Cities areas. Dr. Andres R. Sanchez received his Certificate & Master’s Degree in Periodontics from the prestigious Mayo Clinic in Minnesota. He is a board-certified periodontist and a Diplomate of the American Board of Periodontology. In addition, Dr. Sanchez has been involved as a primary author in more than ten scientific papers published in major periodontal and implant dentistry journals. His associate, Dr. Eleni Voltidi is a prosthodontist who completed her Fellowship in Dental Oncology and Maxillofacial Prosthetics from the prestigious Mayo Clinic in Minnesota. PerioWest provides state-of-the-art dental implant treatment, LANAP® laser therapy, and advanced periodontal care to Eden Prairie, MN and the Twin Cities areas. To learn more about Dr. Sanchez and the services provided at PerioWest, please visit the practice website at http://www.periowestmn.com or call 952-567-7457.

Share article on social media or email:

22-Year-Old Connecticut Recovery Community Organization Launches Marine Conservancy Initiative


More than 500 lbs. of waste pulled from Bridgeport waterways at a recent cleanup.

“People have asked me, what can I do to help? I tell them, how do you see yourself aligning yourself with nature? It’s something I ask myself on a daily basis.”

The Connecticut Community for Addiction Recovery (CCAR) has worked to support individuals and families affected by substance use since 1998. This July marked a new frontier for the long-standing non-profit when they launched a new initiative based on protecting our nation’s oceans, beaches, and waterways. The initiative is called ORCA, the Ocean Recovery Community Alliance.

ORCA hosted its first river cleanup in Stonington on the Mystic River, July 25th, and a beach cleanup at Bridgeport’s Seaside Park the week after, collecting a total of more than 650 lbs. of waste from the two events. The third ORCA cleanup event is scheduled for Sunday, August 16th, 6 PM, at Esker Point Beach in Groton, Connecticut.

The connection between addiction recovery and marine conservancy may not be clear to all but for ORCA’s new Project Coordinator, Kevin Carmignani, the move makes perfect sense.

“The values of the Recovery Community directly align with ORCA’s vision”, says Carmignani, an individual also in personal Recovery. “Recovery is about doing the next right thing and being of service, whether anyone is watching or not. The connection we all share as residents of this planet is powerful and as human beings we should take care of it as a community.”

ORCA seeks to extend this sense of service and community into the realm of oceanic conservancy by performing outreach and providing volunteer outings that bring diverse groups together under a shared purpose and shared values. Those values include respect, integrity, and gratitude, according to Carmignani.

“The environment needs us now more than ever”, says Carmignani. “Because of the pandemic, people are getting outside a lot more and sadly we are seeing more litter on our beaches and rivers. It’s also unfortunate that we are finding a large number of PPE supplies at our cleanups. Now, as a community, we should direct our focus outside to be stewards of the earth.”

The “Community Alliance” is growing. Attendance has gradually increased at each event, new cleanups are being planned, and outreach to prospective community partners is well-underway as support for this unexpected initiative continues to come forward. But ORCA is still seeking partners and contributions to grow their capacity. Specifically, ORCA is looking for a supporter willing to donate a van to serve as a mobile clean-up vehicle and that will be wrapped with ORCA imagery and the logo of the benefactor. Anyone interested in helping can reach out by email at ORCA@ccar.us.

Carmignani is energized and optimistic about the future of ORCA. “People have asked me, what can I do to help? I tell them, how do you see yourself aligning yourself with nature? It’s something I ask myself on a daily basis. We need to work together to build community and share what we discover through our service.”

Share article on social media or email:

NeoTract Designates Dr. Frank (Trey) Moore III as UroLift® Center of Excellence


News Image

“We are proud to name Dr. Frank (Trey) Moore III as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Frank (Trey) Moore III, M.D., Urology Partners of North Texas in Fort Worth, TX, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Moore has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are proud to name Dr. Frank (Trey) Moore III as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “The UroLift System is a safe and effective treatment that allows physicians to treat men in-office under local anesthesia, so they can experience lasting symptom relief within days after receiving treatment.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email: